Clinical trial · Interventional
Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery
Research on the Application of Artificial Intelligence (AI) Assisted Chest Wall Tumor Resection Combined With Personalized 3D Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Chest wall tumors should be completely resection as much as possible while malignant chest wall tumors should be extensively resection. If not completely resection, it will recur in the short time and affect the patient's survival. At present, the surgical resection range mainly relies on preoperative imaging examination and the experience of the surgeon. It lacks precise guidance. This can easily lead to incomplete resection. In addition, the reconstruction materials required for reconstruct the excised chest wall defection are often generated in a standardized manner, lacking intraoperative adjustability. To address this clinical issue, we plan to carry out the research on the application of artificial Intelligence (AI) assisted chest wall tumor resection combined with personalized 3D preformed chest wall defection reconstruction system in chest wall tumor surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chest Wall Tumor | Chest Wall Neoplasm | ALIAS | 0.90 |
| Reconstruction Surgery | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chest wall tumor resection by the artificial intelgent assistent | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- chest wall tumor
- interventionNames
- Device: Chest wall tumor resection by the artificial intelgent assistent
Primary outcomes (1)
- measure
- the tumor status of surgical margin
- timeFrame
- 3 year
- description
- Visible tumor residue with naked eye, tumor cells visible under microscope, no tumor cells observed under microscope
Secondary outcomes (1)
- measure
- Stability after chest wall reconstruction
- timeFrame
- 3 year
- description
- 3D pre formed titanium plates are used for chest wall defect reconstruction. Based on the size and shape of the defect during surgery, suitable titanium plates are selected and fixed with nooses for chest wall defect reconstruction surgery.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18-70 years old, male or female not limited 2. Anesthesia ASA score I-II 3. Malignant tumor of soft tissue in the chest 4. Malignant tumors of ribs, rib cartilage, and sternum 5. Tumors with uncertain or unknown properties of ribs, rib cartilage, and sternum 6. Giant benign tumors of ribs, rib cartilage, and sternum 7. The preoperative examination results indicate that the tumor has not undergone distant metastasis 8. Willing to participate in the research and sign the informed consent form Exclusion Criteria: 1. Patients with distant metastasis detected during preoperative examination 2. Inoperable tumor 3. During the examination, it was discovered that the patient had another type of malignant tumor present 4. ECOG 4 5. Suffering from active or chronic fungal/bacterial/viral infections 6. History of allergy to anesthesia related drugs 7. Heart and lung dysfunction, liver and kidney dysfunction, inability to tolerate surgery 8. Patients with mental disorders who are unable to cooperate with treatment
References
Publications (0)
Data not yet available